Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

279 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria

NCT03157635

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Institut hematologie Centre Hayem CHU paris Saint-Louis Lariboisiere F Widal Hopital St Louis Paris, France
  • Uniklinik RWTH Aachen Aachen, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Universitätsklinikum Ulm Ulm, Germany
View all 15 locations
View Trial Details
Completed

Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT

NCT04173533

Conditions
Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +11 more
Locations
  • The Queen Elizabeth Hospital Birmingham, United Kingdom
  • University Hospital Bristol Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • University Hospital of Wales Cardiff, United Kingdom
View all 20 locations
View Trial Details
Completed

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

NCT00093470

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monocytic Leukemia, +31 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Kaiser Permanente-San Diego Mission San Diego, California, United States
View all 341 locations
View Trial Details
Completed

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

NCT02220985

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
Locations
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions